Our commitment
Leaving no one behind
Our goal is to offer people living with rare diseases a life they never thought possible. By developing transformative treatments, prioritizing access and well-being, and upholding ethical business practices, we are committed to finding solutions and giving them hope.
Society
Every person with rare disease deserves the chance to be treated. Through community-driven initiatives and collaborating with patient advocacy groups, we work to raise awareness and create new partnership models to help make that happen.
Above all, we aim to make treatment more accessible regardless of one’s social standing, income, or where they live. Our global teams continuously join forces to accelerate clinical trials and regulatory processes so that we can bring treatments to patients faster.
Environment
We strive to provide high-quality medicines while advancing responsible production, implementing a number of initiatives to minimize our impact on the environment and promote societal well-being. By doing so, we can continue to create long-term value and positively contribute towards people’s lives.
Read more about our practices in our sustainability report.
Culture & compliance
We foster a culture of open communication and collaboration, ensuring that every team member – from executives to front-line employees – works toward our shared goal.
This commitment extends to our compliance standards, with a focus on rigorous regulatory adherence and ongoing training to ensure all employees understand and uphold them. With a zero-tolerance approach to misconduct and a clear whistleblowing system, we actively manage risks and encourage collective decision-making to ensure everything we do supports our mission.
Corporate governance
Transparency and ethics are fundamental to how we operate. Our robust internal control system regularly assesses our responsibilities, helping us to protect shareholder interests and enhance corporate value. With a majority of independent directors, auditors, and committees, we ensure our governance practices are unbiased and carried out with integrity.
